Cargando…

Far red/near infrared light-induced protection against cardiac ischemia and reperfusion injury remains intact under diabetic conditions and is independent of nitric oxide synthase

Far red/near-infrared light (NIR) promotes a wide range of biological effects including tissue protection but whether and how NIR is capable of acutely protecting myocardium against ischemia and reperfusion injury in vivo is not fully elucidated. Our previous work indicates that NIR exposure immedia...

Descripción completa

Detalles Bibliográficos
Autores principales: Keszler, Agnes, Brandal, Garth, Baumgardt, Shelley, Ge, Zhi-Dong, Pratt, Phillip F., Riess, Matthias L., Bienengraeber, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141548/
https://www.ncbi.nlm.nih.gov/pubmed/25202275
http://dx.doi.org/10.3389/fphys.2014.00305
_version_ 1782331660758417408
author Keszler, Agnes
Brandal, Garth
Baumgardt, Shelley
Ge, Zhi-Dong
Pratt, Phillip F.
Riess, Matthias L.
Bienengraeber, Martin
author_facet Keszler, Agnes
Brandal, Garth
Baumgardt, Shelley
Ge, Zhi-Dong
Pratt, Phillip F.
Riess, Matthias L.
Bienengraeber, Martin
author_sort Keszler, Agnes
collection PubMed
description Far red/near-infrared light (NIR) promotes a wide range of biological effects including tissue protection but whether and how NIR is capable of acutely protecting myocardium against ischemia and reperfusion injury in vivo is not fully elucidated. Our previous work indicates that NIR exposure immediately before and during early reperfusion protects the myocardium against infarction through mechanisms that are nitric oxide (NO)-dependent. Here we tested the hypothesis that NIR elicits protection in a diabetic mouse model where other cardioprotective interventions such as pre- and postconditioning fail, and that the protection is independent of nitric oxide synthase (NOS). NIR reduced infarct size dose dependently. Importantly, NIR-induced protection was preserved in a diabetic mouse model (db/db) and during acute hyperglycemia, as well as in endothelial NOS(−/−) mice and in wild type mice treated with NOS inhibitor L-NAME. In in vitro experiments NIR light liberates NO from nitrosyl hemoglobin (HbNO) and nitrosyl myoglobin (MbNO) in a wavelength-(660-830 nm) and dose-dependent manner. Irradiation at 660 nm yields the highest release of NO, while at longer wavelengths a dramatic decrease of NO release can be observed. Similar wavelength dependence was observed for the protection of mice against cardiac ischemia and reperfusion injury in vivo. NIR-induced NO release from deoxymyoglobin in the presence of nitrite mildly inhibits respiration of isolated mitochondria after hypoxia. In summary, NIR applied during reperfusion protects the myocardium against infarction in an NO-dependent, but NOS-independent mechanisms, whereby mitochondria may be a target of NO released by NIR, leading to reduced reactive oxygen species generation during reperfusion. This unique mechanism preserves protection even during diabetes where other protective strategies fail.
format Online
Article
Text
id pubmed-4141548
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-41415482014-09-08 Far red/near infrared light-induced protection against cardiac ischemia and reperfusion injury remains intact under diabetic conditions and is independent of nitric oxide synthase Keszler, Agnes Brandal, Garth Baumgardt, Shelley Ge, Zhi-Dong Pratt, Phillip F. Riess, Matthias L. Bienengraeber, Martin Front Physiol Physiology Far red/near-infrared light (NIR) promotes a wide range of biological effects including tissue protection but whether and how NIR is capable of acutely protecting myocardium against ischemia and reperfusion injury in vivo is not fully elucidated. Our previous work indicates that NIR exposure immediately before and during early reperfusion protects the myocardium against infarction through mechanisms that are nitric oxide (NO)-dependent. Here we tested the hypothesis that NIR elicits protection in a diabetic mouse model where other cardioprotective interventions such as pre- and postconditioning fail, and that the protection is independent of nitric oxide synthase (NOS). NIR reduced infarct size dose dependently. Importantly, NIR-induced protection was preserved in a diabetic mouse model (db/db) and during acute hyperglycemia, as well as in endothelial NOS(−/−) mice and in wild type mice treated with NOS inhibitor L-NAME. In in vitro experiments NIR light liberates NO from nitrosyl hemoglobin (HbNO) and nitrosyl myoglobin (MbNO) in a wavelength-(660-830 nm) and dose-dependent manner. Irradiation at 660 nm yields the highest release of NO, while at longer wavelengths a dramatic decrease of NO release can be observed. Similar wavelength dependence was observed for the protection of mice against cardiac ischemia and reperfusion injury in vivo. NIR-induced NO release from deoxymyoglobin in the presence of nitrite mildly inhibits respiration of isolated mitochondria after hypoxia. In summary, NIR applied during reperfusion protects the myocardium against infarction in an NO-dependent, but NOS-independent mechanisms, whereby mitochondria may be a target of NO released by NIR, leading to reduced reactive oxygen species generation during reperfusion. This unique mechanism preserves protection even during diabetes where other protective strategies fail. Frontiers Media S.A. 2014-08-22 /pmc/articles/PMC4141548/ /pubmed/25202275 http://dx.doi.org/10.3389/fphys.2014.00305 Text en Copyright © 2014 Keszler, Brandal, Baumgardt, Ge, Pratt, Riess and Bienengraeber. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Physiology
Keszler, Agnes
Brandal, Garth
Baumgardt, Shelley
Ge, Zhi-Dong
Pratt, Phillip F.
Riess, Matthias L.
Bienengraeber, Martin
Far red/near infrared light-induced protection against cardiac ischemia and reperfusion injury remains intact under diabetic conditions and is independent of nitric oxide synthase
title Far red/near infrared light-induced protection against cardiac ischemia and reperfusion injury remains intact under diabetic conditions and is independent of nitric oxide synthase
title_full Far red/near infrared light-induced protection against cardiac ischemia and reperfusion injury remains intact under diabetic conditions and is independent of nitric oxide synthase
title_fullStr Far red/near infrared light-induced protection against cardiac ischemia and reperfusion injury remains intact under diabetic conditions and is independent of nitric oxide synthase
title_full_unstemmed Far red/near infrared light-induced protection against cardiac ischemia and reperfusion injury remains intact under diabetic conditions and is independent of nitric oxide synthase
title_short Far red/near infrared light-induced protection against cardiac ischemia and reperfusion injury remains intact under diabetic conditions and is independent of nitric oxide synthase
title_sort far red/near infrared light-induced protection against cardiac ischemia and reperfusion injury remains intact under diabetic conditions and is independent of nitric oxide synthase
topic Physiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141548/
https://www.ncbi.nlm.nih.gov/pubmed/25202275
http://dx.doi.org/10.3389/fphys.2014.00305
work_keys_str_mv AT keszleragnes farrednearinfraredlightinducedprotectionagainstcardiacischemiaandreperfusioninjuryremainsintactunderdiabeticconditionsandisindependentofnitricoxidesynthase
AT brandalgarth farrednearinfraredlightinducedprotectionagainstcardiacischemiaandreperfusioninjuryremainsintactunderdiabeticconditionsandisindependentofnitricoxidesynthase
AT baumgardtshelley farrednearinfraredlightinducedprotectionagainstcardiacischemiaandreperfusioninjuryremainsintactunderdiabeticconditionsandisindependentofnitricoxidesynthase
AT gezhidong farrednearinfraredlightinducedprotectionagainstcardiacischemiaandreperfusioninjuryremainsintactunderdiabeticconditionsandisindependentofnitricoxidesynthase
AT prattphillipf farrednearinfraredlightinducedprotectionagainstcardiacischemiaandreperfusioninjuryremainsintactunderdiabeticconditionsandisindependentofnitricoxidesynthase
AT riessmatthiasl farrednearinfraredlightinducedprotectionagainstcardiacischemiaandreperfusioninjuryremainsintactunderdiabeticconditionsandisindependentofnitricoxidesynthase
AT bienengraebermartin farrednearinfraredlightinducedprotectionagainstcardiacischemiaandreperfusioninjuryremainsintactunderdiabeticconditionsandisindependentofnitricoxidesynthase